//]]>
Immunology of diabetes V : from bench to bedside / Immunology of diabetes 5 Immunology of diabetes five edited by Carani B. Sanjeevi, Desmond A. Schatz, and Mark A. Atkinson. - Boston, MA : Published by Blackwell Pub. on behalf of the New York Academy of Sciences, 2008. - xiii, 330 p. : ill. (some col.) ; 26 cm. - Annals of the New York Academy of Sciences, v. 1150 0077-8923 ; .

"This volume is the result of the 9th International Congress of the Immunology of Diabetes Society and the American Diabetes Association Research Symposium, held on November 14-18, 2007 at the Loews Miami Beach Hotel, Miami Beach, Florida"--P. vii.

Includes bibliographical references and index.

The Environmental Determinants of Diabetes in the Young (TEDDY) Study -- Immunology of diabetes V: from bench to bedside. Proceedings of the 9th International Congress of the Immunology of Diabetes Society. November 14-18, 2007. Miami, Florida, USA -- Type 1 Diabetes TrialNet--an international collaborative clinical trials network -- What will it take to get therapies approved for type 1 diabetes? -- Islet glia, neurons, and beta cells -- Hedgehog signaling during expansion of human pancreatic islet-derived precursors -- Humanized mice for the study of type 1 diabetes and beta cell function -- Developing a novel model system to target insulin-reactive CD8 T cells -- Lowered expressions of the NF-kappaB family members in dendritic cells from NOD mice are associated with a reduced expression of GATA-2 -- Measurement of CD8 T cell responses in human type 1 diabetes -- Comparative analysis of the islet proteome between NOD/Lt and ALR/Lt mice -- MicroRNA genes -- Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility -- HLA class I supertypes in type 1 diabetic children in an urban children's hospital -- Congenic mapping of the MHC-linked susceptibility to type 1 diabetes in the NOD mouse: at least two genes contribute to the Idd16 effect -- STAT4 polymorphism is associated with early-onset type 1 diabetes, but not with late-onset type 1 diabetes -- From Type 1, through LADA, to type 2 diabetes: a continuous spectrum? -- Molecular scanning of the gene for thioredoxin, an antioxidative and antiapoptotic protein, and genetic susceptibility to type 1 diabetes -- Risk conferred by HLA-DR and DQ for type 1 diabetes in 0-35-year age group in Sweden -- Closing the circle between the bedside and the bench: Toll-like receptors in models of virally induced diabetes -- Toll-like receptors and diabetes -- Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations -- Innate immune pathways in virus-induced autoimmune diabetes -- The distribution of adiponectin receptors on human peripheral blood mononuclear cells -- The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice -- TLR agonists abrogate co-stimulation blockade-induced mixed chimerism and transplantation tolerance -- Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency -- Role of increased ROS dissipation in prevention of T1D -- Apoptotic non-beta cells suppress beta cell antigen-reactive T cells and induce beta cell antigen-specific regulatory T cells -- Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides. TGFbeta plasmid construction and delivery for the prevention of type 1 diabetes -- Intravenous administration of proinsulin 1 or 2-expressing fiber-mutant recombinant adenovirus vector protects against the development of diabetes in NOD mice -- IFN-alpha can both protect against and promote the development of type 1 diabetes -- Update on worldwide efforts to prevent type 1 diabetes -- Tobacco exposure and diabetes-related autoantibodies in children: results from the ABIS study -- Variations in incidence of type 1 diabetes in different municipalities of stockholm -- Eradication of Helicobactor pylori may trigger onset of type 1 diabetes: a case report -- Diabetogenic effects of the most prevalent enteroviruses in Finnish sewage -- Co-transplantation of stromal cells interferes with the rejection of allogeneic islet grafts -- Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes -- Autologous hematopoietic stem cell transplantation for type 1 diabetes -- Time course of islet loss after intraportal transplantation -- Human regulatory CD8 T cells -- Type 1 diabetes versus type 2 diabetes with onset in persons younger than 20 years of age -- Conserved epitopes in the protein tyrosine phosphatase family of diabetes autoantigens -- Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes -- Identification of a major humoral epitope in Slc30A8 (ZnT8) -- SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes -- Prevalence of organ-specific autoantibodies in childhood- and adult-onset type 1 diabetes -- Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults -- Latent autoimmune diabetes in an adult -- The sentinel role of CD8 T cells in regulating CD4 T cell responses to proinsulin in beta-islet cell autoimmunity -- Diverse foxp3 expression in children with type 1 diabetes and celiac disease -- Autoreactive T cell response in CD25-negative fraction of peripheral blood mononuclear cells in established type 1 diabetes -- Gene expression profiles stratified according to type 1 diabetes mellitus susceptibility regions -- Evaluation of cytokine production from peripheral blood mononuclear cells of type 1 diabetic patients -- Insulitis in human type 1 diabetes -- Immunoregulatory pathways controlling progression of autoimmunity in NOD mice -- Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus -- Preparation and testing of diabetes autoantibody controls -- Tumor necrosis factor alpha inducing spatial interactions between calcium-sensing receptor and L-type voltage-dependent calcium channel -- Tracking down immune markers from alternative system pathway factors in a diabetic population.

9781573317337 1573317330


Diabetes--Immunological aspects--Congresses.
Immunogenetics--Congresses.
Diabetes Mellitus, Type 1--immunology.
Diabetes Mellitus, Type 1.--Congresses

Immunology

RC660.A15 / I46 2008

616.462079 / I46

Languages: 
English |